Teva Pharmaceutical Industries sees opportunity in the U.S. healthcare overhaul as more people gain insurance coverage in the company's biggest market. "We're going to see 35 to 40 million people with medical coverage that were outside the circle," CEO Eyal Desheh says. Report (sub. req.)